78 results
Page 2 of 4
424B5
jsqke38zgb 6g
5 Oct 22
Prospectus supplement for primary offering
4:43pm
8-K
EX-1.1
c6j nk1fv7ir0rd3h8
4 Oct 22
Immunovant Announces Pricing of $75.0 Million Underwritten Offering of Common Stock
5:28pm
8-K
EX-10.1
0v9m2al k4mbgf9cu
15 Sep 21
Immunovant Appoints Renee Barnett as Chief Financial Officer
7:23am
424B5
zr1p0b 9f
15 Jan 21
Prospectus supplement for primary offering
12:00am
424B7
rx99k6
15 Jan 21
Prospectus with selling stockholder info
12:00am
S-3
r39 hccd0t1iyr
4 Jan 21
Shelf registration
8:33am
S-3
EX-1.2
ws500u6ejcdv6kl
4 Jan 21
Shelf registration
8:33am
424B3
fwm1c7
12 Nov 20
Prospectus supplement
8:32am